IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0835451
(2004-04-29)
|
발명자
/ 주소 |
|
출원인 / 주소 |
|
인용정보 |
피인용 횟수 :
10 인용 특허 :
18 |
초록
▼
A method and device for delivering a therapy in response to detection of abnormal cardiac rhythms that includes a first circuit delivering a first therapy and a second circuit delivering a second therapy, the second circuit including an energy storage device for storing energy associated with the se
A method and device for delivering a therapy in response to detection of abnormal cardiac rhythms that includes a first circuit delivering a first therapy and a second circuit delivering a second therapy, the second circuit including an energy storage device for storing energy associated with the second therapy and a charging circuit selectively coupled to the storage device to generate the stored energy. A control circuit controls the first circuit and the second circuit to deliver the first therapy substantially simultaneous with the charging of the energy storage device in response to the predetermined event being detected, and decouples the energy storage device from the charging circuit during a redetect period subsequent to delivery of the first therapy. The control circuit recouples the energy storage device and the charging circuit in response to the microprocessor detecting the predetermined event during the redetect period.
대표청구항
▼
What is claimed is: 1. An implantable medical device, comprising: an input circuit sensing cardiac signals; a microprocessor detecting a predetermined event in response to the sensed signals; a first circuit delivering a first therapy; a second circuit for delivering a second therapy, the second ci
What is claimed is: 1. An implantable medical device, comprising: an input circuit sensing cardiac signals; a microprocessor detecting a predetermined event in response to the sensed signals; a first circuit delivering a first therapy; a second circuit for delivering a second therapy, the second circuit including an energy storage device to store energy associated with the second therapy and a charging circuit selectively coupled to the storage device to transfer a predetermined level of the stored energy to the charging circuit; and a control circuit controlling the first circuit and the second circuit to deliver the first therapy substantially simultaneous with coupling of the charging circuit and the energy storage device in response to the predetermined event being detected, and decoupling the energy storage device and the charging circuit during a redetect period subsequent to delivery of the first therapy and prior to the predetermined level of the stored enemy being transferred to the charging circuit, wherein the control circuit recouples the energy storage device and the charging circuit in response to the microprocessor detecting the predetermined event during the redetect period. 2. The device of claim 1, wherein delivery of the first therapy corresponds to a first delivery period and the control circuit controls the first circuit to deliver the first therapy during a second delivery period substantially simultaneous with the recouping of the energy storage device and the charging circuit. 3. The device of claim 1, the control circuit further comprising: means for operating in a first mode to initiate transfer of the stored energy to the charging circuit during delivery of the first therapy; means for operating in a second mode to initiate transfer of the stored energy to the charging circuit subsequent to delivery of the first therapy; and means for transitioning between the first mode and the second mode based on predetermined criteria corresponding to the effectiveness of a previously-delivered first therapy. 4. The device of claim 3, wherein the predetermined criteria corresponds to a first parameter associated with a number of times the microprocessor redetects the predetermined event during the redetect period while operating in the second mode. 5. The device of claim 4, wherein the first parameter corresponds to a number of delivered sequences of the first therapy that do not terminate the predetermined event out of a total number of delivered sequences of the first therapy. 6. The device of claim 4, wherein the predetermined criteria corresponds to a second parameter associated with a number of times the microprocessor does not redetect the predetermined event during the redetect period while operating in the first mode. 7. The device of claim 6, wherein the second parameter corresponds to a number of delivered sequences of the first therapy that terminate the predetermined event out of a total number of delivered sequences of the first therapy. 8. The device of claim 6, wherein the microprocessor determines rhythms associated with the sensed signals, and wherein the control circuit includes means for utilizing different values for the first parameter and the second parameter, each of the values being respectively associated with a rhythm of the determined rhythms occurring during delivery of the first therapy. 9. The device of claim 3, further comprising a storage device coupled to the control circuit to store the predetermined criteria, wherein the predetermined criteria is programmably selected to be specific to a given patient. 10. The device of claim 3, wherein the microprocessor determines rhythms associated with the sensed signals and the predetermined criteria corresponds to a length of one or more of the determined rhythms. 11. The device of claim 3, wherein the microprocessor determines rhythms associated with the sensed signals and the control circuit transitions from the first mode to the second mode in response to a number of a predetermined rhythm of the determined rhythms being detected within a predetermined period of time. 12. The device of claim 3, wherein the predetermined criteria includes criteria associated with a change in a type of cardiac rhythm occurring prior to the delivery of the first therapy. 13. The device of claim 12, wherein the control circuit transitions from the second mode to the first mode in response to the criteria associated with a change in a type of cardiac rhythm occurring during the delivery of the first therapy. 14. The device of claim 3, wherein the control circuit transitions between the first mode and the second mode in response to a length of an episode corresponding to a delivered first therapy. 15. A method for delivering therapy in an implantable medical device, comprising: sensing cardiac signals; detecting a predetermined event in response to the sensed signals; delivering a first therapy, substantially simultaneous with coupling of a charging circuit and an energy storage device to generate a predetermined level of stored energy on the energy storage device, in response to the predetermined event being detected; decoupling the charging circuit and energy storage device during a redetect period subsequent to delivery of the first therapy and prior to the predetermined level of the stored energy being generated on the energy storage device; and recoupling the energy storage device and the charging circuit in response to detecting the predetermined event during the redetect period. 16. The method of claim 15, wherein delivery of the first therapy corresponds to a first delivery period and further comprising delivering the first therapy during a second delivery period substantially simultaneous with the recoupling of the energy storage device and the charging circuit. 17. The method of claim 15, further comprising: operating in a first mode to initiate generation of the stored energy by the charging circuit during delivery of the first therapy; operating in a second mode to initiate generation of the stored energy by the charging circuit subsequent to delivery of the first therapy; and transitioning between the first mode and the second mode based on predetermined criteria corresponding to the effectiveness of a previously-delivered first therapy. 18. The method of claim 17, wherein the predetermined criteria corresponds to a first parameter associated with a number of times the predetermined event is detected during the redetect period while operating in the second mode. 19. The method of claim 18, wherein the first parameter corresponds to a number of delivered sequences of the first therapy that do not terminate the predetermined event out of a total number of delivered sequences of the first therapy. 20. The method of claim 18, wherein the predetermined criteria corresponds to a second parameter associated with a number of times the predetermined event is detected during the redetect period while operating in the first mode. 21. The method of claim 20, wherein the second parameter corresponds to a number of delivered sequences of the first therapy that terminate the predetermined event out of a total number of delivered sequences of the first therapy. 22. The method of claim 20, further comprising: determining rhythms associated with the sensed signals; and utilizing different values for the first parameter and the second parameter, each of the values being respectively associated with a rhythm of the determined rhythms occurring during delivery of the first therapy. 23. The method of claim 17, wherein the predetermined criteria is programmably selected to be specific to a given patient. 24. The method of claim 17, further comprising determining rhythms associated with the sensed signals, wherein the predetermined criteria corresponds to a length of one or more of the determined rhythms. 25. The method of claim 17, further comprising determining rhythms associated with the sensed signals and transitioning from the first mode to the second mode in response to a number of a predetermined rhythm of the determined rhythms being detected within a predetermined period of time. 26. The method of claim 17, wherein the predetermined criteria includes criteria associated with a change in a type of cardiac rhythm occurring prior to the delivery of the first therapy. 27. The method of claim 26, further comprising transitioning from the second mode to the first mode in response to the criteria associated with a change in a type of cardiac rhythm occurring during the delivery of the first therapy. 28. The method of claim 17, further comprising transitioning between the first mode and the second mode in response to a length of an episode corresponding to the delivered first therapy. 29. A computer readable medium having computer executable instructions for performing a method comprising: sensing cardiac signals; detecting a predetermined event in response to the sensed signals; delivering a first therapy, substantially simultaneous with coupling of a charging circuit and an energy storage device to generate a predetermined level of stored energy on the energy storage device, in response to the predetermined event being detected; decoupling the charging circuit and energy storage device during a redetect period subsequent to delivery of the first therapy and prior to the predetermined level of the stored energy being generated on the energy storage device; and recoupling the energy storage device and the charging circuit in response to detecting the predetermined event during the redetect period. 30. An implantable medical device, comprising: means for sensing cardiac signals; means for detecting a predetermined event in response to the sensed signals; means for delivering a first therapy, substantially simultaneous with coupling of a charging circuit and an energy storage device to generate a predetermined level of stored energy on the energy storage device, in response to the predetermined event being detected; means for decoupling the charging circuit and energy storage device during a redetect period subsequent to delivery of the first therapy and prior to the predetermined level of the stored enemy being generated on the energy storage device; and means for recoupling the energy storage device and the charging circuit in response to detecting the predetermined event during the redetect period.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.